Concomitant use is contraindicated. Mavorixafor inhibits CYP2D6, increasing substrate exposure and risk of adverse reactions.
Source: NLP:mavorixafor
Cyp2d6 Substrates Highly Dependent On Cyp2d6 For Clearance Interactions
1 interaction on record
1 interaction on record
Concomitant use is contraindicated. Mavorixafor inhibits CYP2D6, increasing substrate exposure and risk of adverse reactions.
Source: NLP:mavorixafor